KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q3 2025 value amounting to 0.2%.

  • Vertex Pharmaceuticals' Return on Capital Employed rose 2200.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.01% for FY2024, which is 2400.0% down from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Return on Capital Employed stood at 0.2%, which was up 2200.0% from 0.2% recorded in Q2 2025.
  • Vertex Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.33% for Q2 2022, and its period low was 0.04% during Q1 2025.
  • For the 5-year period, Vertex Pharmaceuticals' Return on Capital Employed averaged around 0.19%, with its median value being 0.22% (2023).
  • Per our database at Business Quant, Vertex Pharmaceuticals' Return on Capital Employed crashed by -2600bps in 2024 and then soared by 2200bps in 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.26% in 2021, then grew by 15bps to 0.29% in 2022, then tumbled by -30bps to 0.21% in 2023, then plummeted by -106bps to 0.01% in 2024, then soared by 1716bps to 0.2% in 2025.
  • Its Return on Capital Employed was 0.2% in Q3 2025, compared to 0.2% in Q2 2025 and 0.04% in Q1 2025.